SSMXY SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS
WatchlistSYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS News
Fujirebio and Sysmex Expand CDMO Partnership Into the Field of Neurodegenerative Diseases Under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development and
Urine Cell Analyzer Market Analysis 2023-2028, Profiles of Leading Players Abbott, Sysmex, Siemens Healthcare, ACON Laboratories, ARKRAY, Shenzhen Mindray Bio-Medical Electronics and More
The "Urine Cell Analyzer Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering....
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary
Sysmex's (TYO:6869) unit, Sysmex Shanghai, plans to inject capital to and become a shareholder of IVD Medical Holding's (HKG:1931) subsidiary, Vastec Medical Equipment (Shanghai), as part of a coopera
Fujirebio and Sysmex Enter Into Basic Agreement on Business Collaboration in the Field of Immunoassay
TOKYO & KOBE, Japan--(BUSINESS WIRE)--#IVD--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announce th
Sysmex Corporation Reports Results for Three Months Ended June 30
Japan In-Vitro Diagnostics (IVD) Market Analysis Report 2023-2028: Major Deals, Trends and Recent Developments - Roche Diagnostics Is the Leader, Followed by Sysmex - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments - Forecast to 2028" report has been added to Re
Global Genetic Analysis Research Report 2023: A $45+ Billion Industry by 2032 Featuring Major Players - Bio-Rad Laboratories, Danaher, Sysmex, Agilent Technologies, and Thermo Fisher Scientific
DUBLIN, June 22, 2023 /PRNewswire/ -- The "Genetic Analysis Market Share, Size, Trends, Industry Analysis Report, By Type, By Application, By Technology, By End-Use, By Region, Segment Forecast, 2023
Global Hematology Analyzer Market Analysis Report 2023: A $5.3 Billion Market by 2028 Featuring Key Players- Abbott, Boule, EKF Diagnostics, Shenzhen Mindray Bio-Medical, Sysmex, and Nihon Kohden
Dublin, June 21, 2023 /PRNewswire/ -- The "Hematology Analyzer Market" report has been added to ResearchAndMarkets.com's offering. The global market for hematology analyzers was valued at $3.8 billion in
Sysmex Corporation GAAP EPS of ¥12.40, Revenue of ¥410.5B
Juntendo University, Sysmex, and ThinkCyte Collaborate to Advance the Early Detection and Treatment of Blood Cancer
TOKYO and KOBE, Japan, April 18, 2023 /PRNewswire/ -- Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection an
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development
BALTIMORE and IRVINE, Calif., April 13, 2023 /PRNewswire/ -- Sysmex Inostics Inc., a subsidiary of Japan's Sysmex Corporation and Baltimore-based biotechnology firm, and Genomic Testing Cooperative (
Prosus (OTCMKTS:PROSY) Vs. Sysmex (OTCMKTS:SSMXY) Head to Head Review
Prosus (OTCMKTS:PROSY – Get Rating) and Sysmex (OTCMKTS:SSMXY – Get Rating) are both large-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on
Sysmex (OTCMKTS:SSMXY) Trading 1.1% Higher
Sysmex Co. (OTCMKTS:SSMXY – Get Rating) shares traded up 1.1% during mid-day trading on Friday . The company traded as high as $32.73 and last traded at $32.73. 11,105 shares were traded during tradi
Sysmex Co. (OTCMKTS:SSMXY) Short Interest Update
Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, a decr
Global Coagulation Analyzer Market Report 2022 to 2027: Featuring Abbott Laboratories, Nihon Kohden, Sysmex and Thermo Fisher Scientific Among Others
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Coagulation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to
Sysmex Inostics Opens Cancer Research Excellence Program for Submissions
-- Increases Access to Plasma-Safe-SeqS Technology -- BALTIMORE, Feb. 14, 2023 /PRNewswire/ -- Sysmex Inostics Inc., a subsidiary of Japan's Sysmex Corporation and Baltimore-based biotechnology firm and
Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 68.8%
Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 12,700 shares, a drop of 68.8% fr
Sysmex Corporation GAAP EPS of ¥168.10, Revenue of ¥298.74B
Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Expands By 498.5%
Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 40,700 shares, a
Sysmex Co. (OTCMKTS:SSMXY) Sees Large Decrease in Short Interest
Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the target of a significant decline in short interest in the month of December. As of December 30th, there was short interest totalling 6,800 shares, a de